Breen Michael Martin - Insider Non-Derivative Transactions at GT Biopharma, Inc. (GTBP) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 11, 2023, Breen Michael Martin's relationship to GT Biopharma, Inc. (GTBP) is Director,Officer (Executive Chairman/Interim CEO), and currently has 856,218 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other GTBP insiders.
Data Source: SEC.
Breen Michael Martin - Insider Non-Derivative Transactions of GTBP Common Stock
Breen Michael Martin - Insider Non-Derivative Transactions at GTBP
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 12, 2023 | Acquisition -- (Common Stock) | 200000 | 0.29 | 856218 |
| Apr 12, 2023 | P -- (Common Stock) | 50000 | 0.5 | 656218 |